ABBV
AbbVie Inc. · Healthcare · Drug Manufacturers - General
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +4.6% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 181 | +6 | 1.06B | $267.14B | +9 | −4 |
| Q1 2026 | 179 | -3 | 1.05B | $227.15B | +2 | −6 |
| Q4 2025 | 181 | -3 | 1.14B | $259.75B | +1 | −3 |
| Q3 2025 | 27 | 0 | 673.15M | $155.83B | n/a | −1 |
| Q2 2025 | 25 | +2 | 519.81M | $96.45B | +2 | n/a |
| Q1 2025 | 20 | 0 | 175.76M | $36.80B | n/a | n/a |
| Q4 2024 | 20 | 0 | 178.61M | $31.72B | n/a | n/a |
| Q3 2024 | 19 | 0 | 95.00M | $18.73B | +1 | −1 |
| Q2 2024 | 19 | n/a | 90.79M | $15.55B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasivo) | 36.16M | -1.4% | $7.12B | 0.6% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (pasivo) | 22.98M | +2.2% | $4.54B | 0.6% | ▲ Add | 2 | SEC ↗ |
| 3 | Capital World Investors ✦ | 15.45M | +50.2% | $3.05B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 10.26M | -6.3% | $2.03B | 0.2% | ▼ Trim | 2 | SEC ↗ ×2 |
| 5 | AQR Capital Management ✦ | 1.71M | +21.9% | $333.25M | 0.5% | ▲ Add | 2 | SEC ↗ ×3 |
| 6 | Adage Capital Partners ✦ | 1.66M | +16.7% | $327.38M | 0.6% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.57M | -45.6% | $309.48M | 0.1% | ▼ Trim | 2 | SEC ↗ ×6 |
| 8 | Marshall Wace ✦ | 1.33M | +50.0% | $262.48M | 0.3% | ▲ Add | 2 | SEC ↗ ×2 |
| 9 | Renaissance Technologies ✦ | 1.14M | -12.8% | $224.65M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.09M | +11.7% | $216.24M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 626.91K | -31.8% | $123.80M | 0.2% | ▼ Trim | 2 | SEC ↗ ×2 |
| 12 | Arrowstreet Capital ✦ | 459.15K | +150.8% | $90.67M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 247.19K | Nuevo | $48.82M | 0.1% | New | 1 | SEC ↗ ×2 |
| 14 | Bridgewater Associates ✦ | 204.57K | -29.1% | $40.40M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 45.69K | -0.8% | $9.02M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 38.91K | -2.2% | $7.68M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | GAMCO Investors ✦ | 13.61K | -7.7% | $2.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Dodge & Cox ✦ | 11.01K | 0.0% | $2.17M | 0.0% | Held | 2 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 7.40K | -56.6% | $1.46M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Citadel Advisors | $48.82M | 0.1% |
Posición cerrada
| Harris Associates (Oakmark) | $256,079 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 4,042 tenedores, 1.24B acciones, $260.03B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 32.71K acc. · $8.18M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología